ALIZY vs CB: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ALIZY and CB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ALIZY and CB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Allianz SE is one of the largest insurance and asset-management groups in the world, headquartered in Munich and listed on the Frankfurt (Xetra) exchange under the symbol ALV. It runs three businesses. Property-Casualty sells motor, home, commercial and specialty cover across Europe, Australia, Latin America and Asia, plus global corporate risk through Allianz Commercial and travel and assistance through Allianz Partners. Life/Health sells savings, protection, annuity and health products, with Germany, the US (Allianz Life) and Italy among the biggest markets. Asset Management is PIMCO, the fixed-income specialist, and Allianz Global Investors, which together oversee roughly EUR 2.16 trillion of third-party money. ALIZY is the US dollar American depositary receipt that trades over the counter, with each ADR representing one tenth of an ordinary share.

Full ALIZY guide

Chubb Limited is a global insurance company headquartered in Zurich, Switzerland, and one of the largest publicly traded property and casualty (P&C) insurers in the world. It underwrites commercial and personal P&C insurance, accident and health coverage, reinsurance, and life insurance across roughly 54 countries, serving multinational corporations, businesses, and individuals. Its scale and worldwide network let it service large multinational accounts that smaller carriers cannot, which creates a competitive barrier. The company is widely regarded for underwriting discipline, meaning it prioritizes writing profitable policies over chasing premium volume.

Full CB guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ALIZY drivers: Property-Casualty pricing and underwriting discipline; PIMCO and the asset-management flow cycle.
• CB drivers: Underwriting discipline and margins; Rising investment income.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Natural catastrophes are the most visible risk: a severe European storm or flood season, wildfire or hurricane losses can push the P&C combined ratio up several points in a single quarter. For CB, as a P&C insurer, Chubb is exposed to large catastrophe losses from hurricanes, wildfires, earthquakes, and other severe events, which can compress margins in a bad year.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ALIZY if you believe its drivers more; CB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ALIZY and CB guides.

ALIZY. At roughly EUR 420 per Frankfurt share, Allianz is valued at around EUR 160 billion and trades near 14 to 15 times 2025 core earnings and closer to 13 times what the first-half run rate implies, with a dividend yield around 4%. Those multiples sit at the upper end of where European composite insurers have traded historically, reflecting record profit, a ~20% core return on equity and strong capital, but they are below many US insurers and asset managers. Allianz does not report a conventional revenue line; total business volume (premiums plus asset-management fees) is the closest equivalent, so price-to-sales comparisons with non-insurers are not meaningful.

CB. As of October 16, 2026, Chubb trades near $356, about 12.6 times trailing earnings and 1.8 times book value, broadly in line with large P&C peers even after a 33% one-year gain. Second-quarter 2026 EPS of $7.26 beat consensus by about $0.51. Third-quarter results arrive October 20, 2026, where consensus expects EPS of about $6.80 on roughly $13.5 billion of revenue.

Headline figures (approximate, October 2026): ALIZY shows total business volume (2025) ~EUR 185bn (~USD 205bn), operating profit (2025) ~EUR 17.4bn, up ~8%, operating profit (1h 2026) ~EUR 9.4bn, up ~9%, core eps (2025) ~EUR 28.61, up ~12.5%; CB shows revenue (ttm) ~$61.9 billion, revenue growth (q2 2026) ~6% year over year, net income (ttm) ~$11.2 billion (~18% profit margin), eps ~$28.23 trailing, ~$29.26 forward.

ALIZY and CB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ALIZY and CB exposure against your real portfolio. It is not an investment adviser.